EEF1A1 is Involved the Regulating Neuroinflammatory Processes in Parkinson's Disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Eukaryotic Elongation Factor 1A1 (EEF1A1) is downregulated in Alzheimer's disease hippocampus and linked to PARK2 activity.
• Its specific role in Parkinson's disease (PD) neuroinflammation remains largely uncharacterized.
• This study investigates EEF1A1's function in PD neuroinflammation using a cellular model.

Purpose of the Study:

• To explore the role of Eukaryotic Elongation Factor 1A1 (EEF1A1) in Parkinson's disease (PD) neuroinflammation.
• To identify genes and pathways regulated by EEF1A1 knockdown in U251 cells.
• To elucidate the molecular mechanisms underlying EEF1A1's involvement in PD neuroinflammation.

Main Methods:

• EEF1A1 expression was inhibited in U251 cells using siRNA.
• RNA-sequencing (RNA-seq) identified differentially expressed genes (DEGs) post-knockdown.
• Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed.
• RT-qPCR validated key gene expression changes.

Main Results:

• EEF1A1 knockdown significantly upregulated nine genes: IL-6, GDF15, STC1, MT1E, GPNMB, CCL5, MT1X, A2M, and VIP.
• These upregulated genes were enriched in signaling pathways associated with inflammatory processes.
• Pathway analysis indicated differential roles in PD neuroinflammation, with some genes delaying and others exacerbating the process.

Conclusions:

• EEF1A1 knockdown impacts the expression of key genes involved in PD neuroinflammation.
• Genes like GDF15, STC1, MT1E, MT1X, GPNMB, VIP, and A2M may delay PD neuroinflammation.
• Genes such as IL-6 and CCL5 appear to exacerbate PD neuroinflammation, highlighting EEF1A1's regulatory role.